Procter-Syntex' Femstat 3 to reach retail shelves the first week of April.
This article was originally published in The Tan Sheet
Executive Summary
FEMSTAT 3 TO REACH SHELVES DURING FIRST WEEK OF APRIL, Procter-Syntex announced March 26. The first vaginal yeast infection three-day treatment to be available over-the-counter, the product will be sold nationwide at pharmacies, drug stores, supermarkets and mass merchandisers. The Rx-to-OTC switch application for Femstat-3 was approved by FDA on Dec. 21 ("The Tan Sheet" Jan. 1, p. 1).